## CTSH: Cognizant Technology Solutions Corporation - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.0% in lower entry zone (4.0-10.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (1.5%) confirms momentum alignment. Strong momentum (+1.2% 5-day acceleration). Outperforming sector by 4.7%. Caution: overbought RSI (75).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($77.34)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Indian IT services majors emerge as key bidders for US Bancorp's GCCs**
- Source: Business Standard | 20251204T180933 | Neutral | Relevance: 63%
- Indian IT services majors like TCS, Wipro, Cognizant, and ANSR are key bidders for a mandate from US Bancorp to establish two global capability centers (GCCs) in India. The fifth-largest US bank plans to insource a significant portion of its technology work and is looking to build centers in Hyderabad and Chennai. The Hyderabad unit is expected to be wholly owned, while the Chennai facility may operate under a build-operate-transfer model.

**2. Amdocs Limited (DOX): A Bull Case Theory**
- Source: Insider Monkey | 20251205T150900 | Somewhat-Bullish | Relevance: 62%
- This article summarizes a bullish thesis on Amdocs Limited (DOX) from David J. Waldron of Quality Value Investing. Amdocs, a dividend-paying mid-cap IT services company, benefits from sticky customer relationships, consistent dividend policy, and strategic share repurchases. Despite underperforming the S&P 500 in revenue growth, its strong gross margins, double-digit owners' earnings growth, and robust capital allocation make it an attractive investment.

**3. Will IBM Cloud Powering Zyphraâ€™s AMD-Based Frontier AI Training Change International Business Machines' (IBM) Narrative?**
- Source: Simply Wall Street | 20251205T062632 | Neutral | Relevance: 60%
- IBM Cloud's role in Zyphra's frontier AI training, using an AMD-based platform for ZAYA1, reinforces IBM's relevance in high-performance AI. While this collaboration highlights IBM Cloud's capabilities, it doesn't fundamentally alter IBM's near-term investment narrative which remains focused on hybrid cloud and AI software growth. The key challenge for IBM is demonstrating that these high-profile AI wins translate into significant revenue and margin contributions to support its growth thesis against existing legacy pressures and a high debt load.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | William Blair | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | William Blair | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 18 ($0.00M) |
| Sells | 18 ($2.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.8%)
- Blackrock Inc.: 10.5% (-0.2%)
- JPMORGAN CHASE & CO: 8.2% (+108.3%)
- State Street Corpora: 5.2% (-0.9%)
- Pzena Investment Man: 3.7% (+1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.50 elevated, pricing in significant growth expectations. Forward P/E 14.4x stretched relative to 7% growth. Quality metrics strong (ROA 10%). Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.35), $1.2B free cash flow. Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.8B |
| Beta | 0.97 |
| 52W Range | $65.15 - $90.82 |
| Short Interest | 7.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.50 |
| Forward P/E | 14.4 |
| Current P/E | 15.4 |
| YoY Growth | 7.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.8% to 5.0% (+1.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 1.5% confirms short-term momentum alignment. AM_20 at 7.5% shows strong absolute momentum above own 20MA. Outperforming sector by 4.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 75, risk of mean reversion. OFD pattern: +STL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.04% (CS: 86) | Strong |
| RSI_14 | 75.4 | Overbought |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.073x | Above |
| vs SMA50 | 1.133x | Above |
| vs SMA200 | 1.082x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $80.72
- **Stop Loss:** $77.34 (4.2% risk)
- **Target:** $85.79 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 295
- **Position Value:** $23,812.40
- **Portfolio %:** 23.81%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-04 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.39 | +6.7% |
| 2025Q2 | $1.26 | $1.31 | +4.0% |
| 2025Q1 | $1.20 | $1.23 | +2.5% |
| 2024Q4 | $1.13 | $1.21 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*